MAPS Canada is a non-profit organization committed to legalizing psychedelic medicine by conducting honest and careful research investigating the safety and efficacy of psychedelic-assisted therapy to treat a variety of mental health disorders, funded 100% by public donation.
Vancouver is one of 15 international Phase 3 sites for MAPS’ MDMA-Assisted Psychotherapy for PTSD study which the BC Centre on Substance Use (BCCSU) will be recruiting participants for soon. In August 2017, MDMA-Assisted Psychotherapy for PTSD was granted Breakthrough Therapy Designation by the FDA in recognition of outstanding Phase 2 results. This novel treatment is on track to be legalized by 2021 so please help us raise awareness, share knowledge, and provide hope to those suffering from treatment-resistant PTSD. Visit www.maps.org/mdma to learn more.
We hope you can join us for an informative and inspiring evening featuring presentations by some of Canada’s top psychedelic leaders who collectively have first-hand experience healing trauma and addiction with Ayahuasca, MDMA, and Ibogaine!